Back to Search
Start Over
Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy
- Source :
- Journal of Managed Care & Specialty Pharmacy. 27:1142-1152
- Publication Year :
- 2021
- Publisher :
- Academy of Managed Care Pharmacy, 2021.
-
Abstract
- BACKGROUND: Before 2007, erythropoiesis-stimulating agents (ESAs) were the highest-expenditure drug in the Medicare system. In 2007, CMS issued a reimbursement policy change for ESAs used by cancer...
- Subjects :
- Male
medicine.medical_specialty
medicine.drug_class
Pharmaceutical Science
Pharmacy
Medicare
Reimbursement Mechanisms
hemic and lymphatic diseases
Humans
Medicine
Medicare reimbursement
Healthcare Disparities
Intensive care medicine
health care economics and organizations
Reimbursement
Aged
Retrospective Studies
Aged, 80 and over
business.industry
Health Policy
Racial Groups
Cancer
Anemia
Health Care Costs
Erythropoiesis-stimulating agent
medicine.disease
Anemia management
United States
Racial ethnic
Policy
Hematinics
Kidney Failure, Chronic
Female
sense organs
business
Medical costs
SEER Program
Subjects
Details
- ISSN :
- 23761032 and 23760540
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Journal of Managed Care & Specialty Pharmacy
- Accession number :
- edsair.doi.dedup.....8966edcccd3a5a7b2a57dfd012242836
- Full Text :
- https://doi.org/10.18553/jmcp.2021.27.8.1142